BNZU - Overview: Benzodiazepines Confirmation, Random, Urine

Detecting drug use involving benzodiazepines such as alprazolam, chlordiazepoxide, clonazepam, diazepam, midazolam, oxazepam, temazepam, clobazam, flunitrazepam, flurazepam, lorazepam, prazepam, triazolam, and zolpidem

AC1Q - Overview: Anti-C1q Antibodies, IgG, Serum

Evaluating patients with suspected anti-C1q vasculitis Predicting renal involvement in patients with systemic lupus erythematosus Detection of anti-C1q antibodies in serum

FRASP - Overview: Raspberry IgG

Raspberry IgG

MEPHS - Overview: Mephobarbital and Phenobarbital, Serum

Monitoring of mephobarbital and phenobarbital therapy

BUTAS - Overview: Butalbital, Serum

Monitoring butalbital therapy

MPA - Overview: Mycophenolic Acid, Serum

Monitoring therapy to ensure adequate blood levels and avoid over-immunosuppression

FLUOX - Overview: Fluoxetine, Serum

Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance

GABA - Overview: Gabapentin, Serum

Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients

CYCPK - Overview: Cyclosporine, Peak, Blood

Monitoring whole blood peak cyclosporine concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...

FENTS - Overview: Fentanyl, Serum

Monitoring fentanyl therapy